Characteristics and 2‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF

Abstract Aims This study aimed to describe baseline characteristics of patients with atrial fibrillation (AF) at risk of stroke with and without history of heart failure (HF) and report 2‐year outcomes in the dabigatran‐treated subset of a prospective, global, observational study (GLORIA‐AF). Method...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sergio J. Dubner, Christine Teutsch, Menno V. Huisman, Hans‐Christoph Diener, Jonathan Halperin, Kenneth J. Rothman, Chang‐Sheng Ma, Eduardo Chuquiure‐Valenzuela, Jutta Bergler‐Klein, Kristina Zint, Lionel Riou França, Shihai Lu, Miney Paquette, Gregory Y.H. Lip
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Oxford University Press 2020-10-01
Edice:	ESC Heart Failure
Témata:	Anticoagulation Atrial fibrillation Dabigatran Heart failure Major bleed Stroke
On-line přístup:	https://doi.org/10.1002/ehf2.12857
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!